Onconova Therapeutics Inc (ONTX)
1.03
+0.06
(+6.19%)
USD |
NASDAQ |
Mar 28, 16:00
1.03
0.00 (0.00%)
After-Hours: 16:44
Onconova Therapeutics Revenue (TTM): 0.226M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 0.226M |
June 30, 2023 | 0.226M |
March 31, 2023 | 0.226M |
December 31, 2022 | 0.226M |
September 30, 2022 | 0.226M |
June 30, 2022 | 0.226M |
March 31, 2022 | 0.226M |
December 31, 2021 | 0.226M |
September 30, 2021 | 0.227M |
June 30, 2021 | 0.236M |
March 31, 2021 | 0.235M |
December 31, 2020 | 0.231M |
September 30, 2020 | 0.204M |
June 30, 2020 | 0.201M |
March 31, 2020 | 2.167M |
December 31, 2019 | 2.183M |
September 30, 2019 | 2.212M |
June 30, 2019 | 2.269M |
March 31, 2019 | 0.732M |
December 31, 2018 | 1.228M |
September 30, 2018 | 1.312M |
June 30, 2018 | 1.302M |
Date | Value |
---|---|
March 31, 2018 | 1.141M |
December 31, 2017 | 0.787M |
September 30, 2017 | 0.817M |
June 30, 2017 | 2.358M |
March 31, 2017 | 4.282M |
December 31, 2016 | 5.546M |
September 30, 2016 | 14.97M |
June 30, 2016 | 14.94M |
March 31, 2016 | 12.82M |
December 31, 2015 | 11.46M |
September 30, 2015 | 1.973M |
June 30, 2015 | 0.465M |
March 31, 2015 | 0.467M |
December 31, 2014 | 0.80M |
September 30, 2014 | 2.616M |
June 30, 2014 | 3.618M |
March 31, 2014 | 4.084M |
December 31, 2013 | 4.753M |
September 30, 2013 | 5.792M |
June 30, 2013 | 47.48M |
March 31, 2013 | 47.11M |
December 31, 2012 | 46.19M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.201M
Minimum
Jun 2020
2.269M
Maximum
Jun 2019
0.6687M
Average
0.226M
Median
Dec 2021
Revenue (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 14.64M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Ampio Pharmaceuticals Inc | -- |